Literature DB >> 19845770

A unique domain in RANK is required for Gab2 and PLCgamma2 binding to establish osteoclastogenic signals.

Yuu Taguchi1, Jin Gohda, Takako Koga, Hiroshi Takayanagi, Jun-ichiro Inoue.   

Abstract

TRAF6 is essential for osteoclastogenesis and for both RANK- and CD40-mediated activation of IKK and MAPKs. RANK, but not CD40, can promote osteoclastogenesis because only RANK induces NFATc1 activation through PLCgamma2-induced Ca(2+) oscillations together with the co-stimulatory signals emanating from immune receptors linked to ITAM-containing adaptors. These previous data suggest that RANK harbors a unique domain that functions in concert with the TRAF6-binding site in osteoclastogenesis. Here we identify such a domain, highly conserved domain in RANK (HCR), which is dispensable for the early phase of RANK and ITAM signaling but is essential for their late-phase signaling, including sustained activation of NF-kappaB and PLCgamma2 leading to NFATc1 activation. HCR recruits an adaptor protein, Gab2, which further associates with PLCgamma2 in the late phase. Formation of the HCR-mediated signaling complex could account for the sustained activation of NF-kappaB and PLCgamma2. The present study identifies HCR as a unique domain that plays a critical role in the long-term linkage between RANK and ITAM signals, providing a molecular basis for therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19845770     DOI: 10.1111/j.1365-2443.2009.01351.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  18 in total

Review 1.  Osteoclasts: New Insights.

Authors:  Xu Feng; Steven L Teitelbaum
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

2.  The IVVY Motif and Tumor Necrosis Factor Receptor-associated Factor (TRAF) Sites in the Cytoplasmic Domain of the Receptor Activator of Nuclear Factor κB (RANK) Cooperate to Induce Osteoclastogenesis.

Authors:  Joel Jules; Shunqing Wang; Zhenqi Shi; Jianzhong Liu; Shi Wei; Xu Feng
Journal:  J Biol Chem       Date:  2015-08-14       Impact factor: 5.157

Review 3.  Selective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis.

Authors:  Joel Jules; Jason W Ashley; Xu Feng
Journal:  Expert Opin Ther Targets       Date:  2010-09       Impact factor: 6.902

4.  C/EBPα transcription factor is regulated by the RANK cytoplasmic 535IVVY538 motif and stimulates osteoclastogenesis more strongly than c-Fos.

Authors:  Joel Jules; Wei Chen; Xu Feng; Yi-Ping Li
Journal:  J Biol Chem       Date:  2017-11-09       Impact factor: 5.157

5.  C/EBPα and PU.1 exhibit different responses to RANK signaling for osteoclastogenesis.

Authors:  Joel Jules; Yi-Ping Li; Wei Chen
Journal:  Bone       Date:  2017-10-12       Impact factor: 4.398

6.  Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations.

Authors:  Saida Mebarek; Abdelkarim Abousalham; David Magne; Le Duy Do; Joanna Bandorowicz-Pikula; Slawomir Pikula; René Buchet
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

7.  Early estrogen-induced gene 1, a novel RANK signaling component, is essential for osteoclastogenesis.

Authors:  Han Kyoung Choi; Hye Ri Kang; Eutteum Jung; Tae Eon Kim; Jing Jing Lin; Soo Young Lee
Journal:  Cell Res       Date:  2013-03-12       Impact factor: 25.617

8.  Molecular mechanisms of triggering, amplifying and targeting RANK signaling in osteoclasts.

Authors:  Yukiko Kuroda; Koichi Matsuo
Journal:  World J Orthop       Date:  2012-11-18

9.  CCAAT/Enhancer-binding Protein α (C/EBPα) Is Important for Osteoclast Differentiation and Activity.

Authors:  Joel Jules; Wei Chen; Xu Feng; Yi-Ping Li
Journal:  J Biol Chem       Date:  2016-04-20       Impact factor: 5.157

10.  Interaction of Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) and Vav3 in the Receptor Activator of Nuclear Factor κB (RANK) Signaling Complex Enhances Osteoclastogenesis.

Authors:  Jiyeon Yu; Hyeongseok Yun; Bongjin Shin; Yongjin Kim; Eui-Soon Park; Seunga Choi; Jungeun Yu; Dulshara Sachini Amarasekara; Sumi Kim; Jun-Ichiro Inoue; Matthew C Walsh; Yongwon Choi; Masamichi Takami; Jaerang Rho
Journal:  J Biol Chem       Date:  2016-08-09       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.